Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)
China flag China · Delayed Price · Currency is CNY
23.27
+0.11 (0.47%)
Apr 28, 2026, 3:04 PM CST

SHE:000766 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,1701,1691,3221,4701,4701,514
Other Revenue
1.261.260.53.570.581.32
1,1711,1701,3231,4731,4711,515
Revenue Growth (YoY)
-11.72%-11.54%-10.23%0.18%-2.95%36.31%
Cost of Revenue
315.51325.01329.03381.17352.93350.18
Gross Profit
855.27844.95993.531,0921,1181,165
Selling, General & Admin
686.21677.13789.26905923.47986.24
Research & Development
44.2639.8550.3445.8264.9163.52
Other Operating Expenses
14.9814.089.8810.6211.575.4
Operating Expenses
744.82730.43853.14970.43996.861,052
Operating Income
110.45114.52140.39121.75120.96113.33
Interest Expense
-81.89-81.89-84.98-83.15-88.79-97.19
Interest & Investment Income
775.284.0211.526.36
Other Non Operating Income (Expenses)
-5.19-4.43-2.661.23-3.643.47
EBT Excluding Unusual Items
30.3635.258.0343.8540.0245.98
Gain (Loss) on Sale of Investments
0.38-0.030.03-2.61-0.05-0.01
Gain (Loss) on Sale of Assets
-0.05-0.05-0.17-0.21-0.020.83
Asset Writedown
-0.28-0.28-0.120.22-0.11-1.49
Other Unusual Items
7.867.869.3213.6110.3314.32
Pretax Income
38.2942.7167.0954.8650.1759.62
Income Tax Expense
6.538.5111.1111.6320.9925.64
Earnings From Continuing Operations
31.7534.255.9843.2329.1933.99
Minority Interest in Earnings
0.080.080.460.710.961.29
Net Income
31.8334.2956.4443.9330.1535.27
Net Income to Common
31.8334.2956.4443.9330.1535.27
Net Income Growth
-45.89%-39.25%28.46%45.71%-14.52%-
Shares Outstanding (Basic)
8598579418791,005882
Shares Outstanding (Diluted)
8598579418791,005882
Shares Change (YoY)
-8.67%-8.87%7.05%-12.57%13.97%-9.24%
EPS (Basic)
0.040.040.060.050.030.04
EPS (Diluted)
0.040.040.060.050.030.04
EPS Growth
-40.76%-33.33%20.00%66.67%-25.00%-
Free Cash Flow
42.340.99113.5886.11174.42112.85
Free Cash Flow Per Share
0.050.050.120.100.170.13
Gross Margin
73.05%72.22%75.12%74.13%76.00%76.89%
Operating Margin
9.43%9.79%10.62%8.26%8.22%7.48%
Profit Margin
2.72%2.93%4.27%2.98%2.05%2.33%
Free Cash Flow Margin
3.61%3.50%8.59%5.85%11.86%7.45%
EBITDA
170.69175.63204.98196.49192.58182.72
EBITDA Margin
14.58%15.01%15.50%13.34%13.09%12.06%
D&A For EBITDA
60.2461.1164.5974.7471.6269.39
EBIT
110.45114.52140.39121.75120.96113.33
EBIT Margin
9.43%9.79%10.62%8.26%8.22%7.48%
Effective Tax Rate
17.06%19.92%16.56%21.20%41.83%42.99%
Revenue as Reported
1,1701,1701,3231,4731,4711,515
Advertising Expenses
-274.54249.73352.83298.68375.06
Source: S&P Global Market Intelligence. Standard template. Financial Sources.